Filing Details
- Accession Number:
- 0001235802-22-000126
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-29 17:06:41
- Reporting Period:
- 2022-11-28
- Accepted Time:
- 2022-11-29 17:06:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1253176 | Vapotherm Inc | VAPO | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1753455 | John Landry | 100 Domain Drive Exeter NH 03833 | Svp & Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-11-28 | 45,000 | $0.76 | 213,074 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-28 | 90,000 | $0.79 | 303,074 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-28 | 13,550 | $0.79 | 13,550 | No | 4 | P | Indirect | Roth IRA I |
Common Stock | Acquisiton | 2022-11-28 | 3,400 | $0.76 | 3,400 | No | 4 | P | Indirect | Roth IRA II |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Indirect | Roth IRA I |
No | 4 | P | Indirect | Roth IRA II |
Footnotes
- Includes 61,784 shares that will be issued over time upon vesting and settlement of restricted stock units granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan and 45,000 shares held by the reporting person's Roth IRA.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.75 to $0.802, inclusive. The reporting person undertakes to provide to Vapotherm, Inc., any security holder of Vapotherm, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4.
- The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.